Origin Agritech Strengthens Gene Editing Platform through Patent License Agreement with Shunfeng BioTech

Accessibility StatementSkip Navigation Commercialization Roadmap: Advancing Biosafety Evaluation Origin Agritech has initiated the biosafety assessment process for the edited lines. Additionally, this license agreement provides a substantial advantage by facilitating biosafety approval for Origin's current and future gene editing transformants utilizing Hi-3 one-step gene-editing method, for some of which the Company has already applied. The Company estimates obtaining final biosafety certification will req ...